phase readout
saveNCT06467084: Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: KalVista Pharmaceuticals, Ltd.. Phase: PHASE3. Conditions: Hereditary Angioedema
view source ↗
comments(0)
5-min edit window · permanent after that